Testostérone en cas de dysfonction érectile

Andrianne, Robert

Download

Article (Scientific journals)

Testostérone en cas de dysfonction érectile

Andrianne, Robert

2010 • In Louvain Medical, 129 (2), p. 41-42

Permalink
https://hdl.handle.net/2268/80592

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

227547-11-ANDRIANNE.pdf

Publisher postprint (77.68 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

dysfonction érectile; testostérone

Abstract :

[fr] Pour une bonne érection, il faut surtout de l’oxygène et le taux de testostérone est le plus souvent suffisant. Néanmoins, malgré le mérite clinique peu intéressant de l’effet thérapeutique isolé de la testostérone chez le patient en dysfonction érectile, la recherche et le traitement d’un hypogonadisme reste vivement recommandé pour d’autres importantes raisons.

Disciplines :

Urology & nephrology

Author, co-author :

Andrianne, Robert ; Université de Liège - ULiège > Urologie

Language :

English

Title :

Testostérone en cas de dysfonction érectile

Publication date :

2010

Journal title :

Louvain Medical

ISSN :

0024-6956

Publisher :

Université Catholique de Louvain. Faculté de Médecine, Louvain, Belgium

Volume :

129 (2)

Pages :

S41-42

Available on ORBi :

since 31 December 2010

Statistics

Number of views

155 (4 by ULiège)

Number of downloads

782 (4 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

Bibliography

Buvat, J., Maggi, M., Guay, A., Gorren, L., Kaufman, J., Morgentaler, A., Proceedings of the International Consultation on Sexual Medicine, , Parts, France, July 10-13 : Report of committe 14 : Endocrine Aspects of Male Sexual Dysfunctions
Buvat, J., Bou Jaoudé, G., Significance of hypogonadism in erectile dysfunction (2006) World J Urol, 24, pp. 657-667
Earie, C.M., Stuckey, B.G., Biochemical screening in the assessment of erectile dysfunction : WWhat tests decide future therapy ? (2003) Urology, 62, pp. 727-731
Jannini, E.A., Screponi, E., Carosa, E., Lack of sexual activity from erectile dysfunction is associated with a reversible reduction in serum testosterone (1999) IntJAndrol, 22, pp. 385-392
Kim, Y.C., Buvat, J., Carson, C.C., Gooren, U., Jarow, J., Raifer, J., Vermeulen, A., Endocrine and metabolic aspects including treatment (1999) Proceedings of the First International Consultation on Erectile Dysfunction, pp. 205-240. , Erectile Dysfunction, K Jardin, G. Wagner, S. Khoury, F. Giuliano, H. Padma Nathan, R. Rosen, July 1-3, Paris, Plymbridge, Plymouth, UK
Morales, A., Johnson, B., Heaton, J.W., Clark, A., Oral androgens in the treatment of hypogonadal impotent men (1994) J Urol, 152, pp. 1115-1118
Morales, A., Johnston, B., Heaton, J.P.W., Lundie, M., Testosterone supplementation for hypogonadal impotence : AAssessment of biochemical measures and therapeutic outcomes (1997) J Urol, 157, pp. 849-854
Wylie, K., Davies-South, D., A study of treatment choices in men with erectile dysfunction and reduced androgen levels (2004) J Sex and Mar Ther, 30, pp. 107-114
Buvat, J., Lemaire, A., Endocrine screening in 1022 men with erectile dysfunction: Clinical significance and cost-effective strategy (1997) J Urol, 158, pp. 764-767
Carosa, E., Martini, P., Brandetti, F., Type v phosphodiesterase inhibitor treatments for erectile dysfunction increase testosterone levels (2004) Clin Endocrinol (Oxf), 61, pp. 382-386
Andrianne, R., Chabot, C., Penile prosthesis implantation increases total testosterone level (2008) J Sex Research, 45 (2), pp. 90-117
Bou Jaoudé, G., Jacques, Buvat., Déficit en Testostérone et Dysfonction Erectile Communication SFMS
Schleich, F., Legros, J.J., Effects of androgen substation on lipid profile in adult and ageing hypogonadal male (2004) Europ J Endocrinol, 151 (4), pp. 415-424
Smeets, L., Legros, J.J., Cœur et androgenes (2004) Rev Med Lg, 59 (7-8), pp. 439-1434
Wang, C., Nieschlag, E., Swerdloff, R., Behre, H.M., Hellstrom, W.J., Gooren, U., Investigation, treatment and monitoring of late-onset hypogonadism in males (2009) Int J Androl, 32, pp. 1-10
Caminiti, G., Vblterrani, M., Lellamo, F., Marazzi, G., Massaro, R., Miceli, M., Effect of long-acting testosterone treatment on functjonnal exercise capacity, skeletal muscle performance, insulin resistance and baroreflex sensitivity in elderly patient with congestive heart failure (2009) J Am Coll Cardiol, 54, pp. 919-927
Shabsigh, R., Arver, S., Channer, K.S., Eardley, I., Fabbri, A., Gooren, L., Heufelder, A., Zitzmann, M., The triad of erectile dysfunction, hypogonadism and the metabolic syndrome (2008) International Journal of Clinical Practice, 62 (5), pp. 791-798. , DOI 10.1111/j.1742-1241.2008.01696.x
Buvat, J., Bou Jaoudé, G., Significance of hypogonadism in erectile dysfunction (2006) World J Urol, 24, pp. 657-667
Morelli, A., Filippi, S., Mancina, R., Luconi, M., Vignozzi, L., Marini, M., Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa (2004) Endocrinology, 145, pp. 2253-2263
Tralsh, A.M., Park, K., Dhir, V., Kim, N.N., Moreland, R.B., Goldstein, I., Effects of castration and androgen replacement on erectile function in a rabbit model (1999) Endocrinology, 140, pp. 1861-1868
Foresta, C., Caretta, N., Rossato, M., Garolla, A., Feriin, A., Role of androgens in erectile function (2004) J Urol, 171, pp. 2358-2362
Aversa, A., Isidori, A.M., Spera, G., Lenzi, A., Fabbrl, A., Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction (2003) Clin Endocrinol (Oxf), 58, pp. 632-638
Kalinchenko, S.Y., Gl, K., Gontcharov, N.P., Katsiya, G.V., Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone (2003) Aging Male, 6, pp. 94-99
Shamloul, R., Ghanem, H., Fahmy, I., El-Meleigy, A., Ashoor, S., Elnashaar, A., Kamel, I., Testosterone therapy can enhance erectile function response to Sildenafil in patients with PADAM : AA pilot study (2005) J Sex Med, 2, pp. 559-564
Rosenthal, B.D., May, N.R., Metro, M.J., Haikaway, R.C., Ginsberg, P.C., Adjunctive use of AndroGel (testosterone gel) with sildenafil to treat erectile dysfunction in men with acquired androgen deficiency syndrome after failure using sildenafil alone (2006) Urology, 67 (3), pp. 571-574
Guay, A.T., Perez, J.B., Jacobson, J., Newton, R.A., Efficacy and safety of Sildenafil citrate for treatment of Erectile Dysfunction in a population with associated organic risk factors (2001) J Androl, 22, pp. 793-797